Poland· PL-100533811
Macmiror Complex 500
A nystatin, kombinationen product containing nifuratelum + nystatinum, registered in Poland by InPharm Sp. z o.o.. The same ATC class is registered in 3 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Nystatin, kombinationen is registered in 3 of 19 countries.
Countries holding a registration under ATC G01AA51 (nystatin, kombinationen), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 2 of them publish a price we can compare per daily dose
Nystatin, kombinationen · ATC G01AA51
3 / 19 countries
- Canada
- Czechiaprice
- Polandprice
The record
At a glance
URPL (Poland)- Active substance
- Nifuratelum + Nystatinum
- Manufacturer
- InPharm Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- G01AA51
- ATC class
- Nystatin, Kombinationen
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909991595319
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Nystatin, kombinationen in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Authorised across Europe · EMA
The same active substance is authorised in 10 EEA countries. Names it is sold under:
- Bulgaria · Макмирор Комплекс
- Czechia · Macmiror Complex
- Croatia · Macmiror Complex
- Hungary · Macmiror Complex
- Italy · Inimur Complex, Macmiror Complex
- Lithuania · Macmiror Complex
- Latvia · Livormac
- Portugal · Dafnegil
- Romania · Macmiror Complex, Macmirorcomplex
- Slovakia · Macmiror Complex, Macmiror Complex 500
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/0c2f2c06-b688-4ef2-8d44-d82601073c42 GET /v1/drugs/0c2f2c06-b688-4ef2-8d44-d82601073c42?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Kapsułki dopochwowe, miękkie",
"source": "urpl",
"strength": "500 mg + 200000 j.m.",
"packaging": "05909991595319 ¦ Rp ¦ 166008\n12 kaps.",
"substance": "Nifuratelum/500 mg + Nystatinum/200000 j.m.",
"common_name": "Nifuratelum + Nystatinum",
"pl_product_id": "100533811",
"pozwolenie_nr": "080/26",
"auth_procedure": "IR",
"authorisation_validity": "2031-03-03"
}See everything about nystatin, kombinationen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.